药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chlorphentermine
PRO-542
Estradiol benzoate may increase the thrombogenic activities of PRO-542.
Chlorphentermine
Ustekinumab
Estradiol benzoate may increase the thrombogenic activities of Ustekinumab.
Chlorphentermine
Veltuzumab
Estradiol benzoate may increase the thrombogenic activities of Veltuzumab.
Chlorphentermine
Farletuzumab
Estradiol benzoate may increase the thrombogenic activities of Farletuzumab.
Chlorphentermine
Ramucirumab
Estradiol benzoate may increase the thrombogenic activities of Ramucirumab.
Chlorphentermine
Enokizumab
Estradiol benzoate may increase the thrombogenic activities of Enokizumab.
Chlorphentermine
Iratumumab
Estradiol benzoate may increase the thrombogenic activities of Iratumumab.
Chlorphentermine
AMG 108
Estradiol benzoate may increase the thrombogenic activities of AMG 108.
Chlorphentermine
Otelixizumab
Estradiol benzoate may increase the thrombogenic activities of Otelixizumab.
Chlorphentermine
Briakinumab
Estradiol benzoate may increase the thrombogenic activities of Briakinumab.
Chlorphentermine
NAV 1800
Estradiol benzoate may increase the thrombogenic activities of NAV 1800.
Chlorphentermine
XTL-001
Estradiol benzoate may increase the thrombogenic activities of XTL-001.
Chlorphentermine
Obiltoxaximab
Estradiol benzoate may increase the thrombogenic activities of Obiltoxaximab.
Chlorphentermine
Girentuximab
Estradiol benzoate may increase the thrombogenic activities of Girentuximab.
Chlorphentermine
Rozrolimupab
Estradiol benzoate may increase the thrombogenic activities of Rozrolimupab.
Chlorphentermine
CR002
Estradiol benzoate may increase the thrombogenic activities of CR002.
Chlorphentermine
Bavituximab
Estradiol benzoate may increase the thrombogenic activities of Bavituximab.
Chlorphentermine
Fontolizumab
Estradiol benzoate may increase the thrombogenic activities of Fontolizumab.
Chlorphentermine
Matuzumab
Estradiol benzoate may increase the thrombogenic activities of Matuzumab.
Chlorphentermine
Labetuzumab
Estradiol benzoate may increase the thrombogenic activities of Labetuzumab.